VTRS Logo

Viatris Inc. (VTRS) 

NASDAQ
Market Cap
$13.07B
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
934 of 945
Rank in Industry
56 of 57

Largest Insider Buys in Sector

VTRS Insider Trading Activity

VTRS Median Price and Trade Amounts History Chart

About Viatris Inc.

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system â€¦

Insider Activity of Viatris Inc.

Over the last 12 months, insiders at Viatris Inc. have bought $0 and sold $15.86M worth of Viatris Inc. stock.

On average, over the past 5 years, insiders at Viatris Inc. have bought $558,372 and sold $8.13M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 19 shares for transaction amount of $171 was made by KORMAN HARRY (director) on 2023‑10‑26.

List of Insider Buy and Sell Transactions, Viatris Inc.

2024-11-11SaleSee Remarks
26,925
0.0022%
$12.88$346,686-4.51%
2024-09-12Saledirector
200,000
0.0166%
$11.67$2.33M+0.60%
2024-08-30Saledirector
50,000
0.0042%
$12.00$600,000-2.40%
2024-08-28Saledirector
50,000
0.0042%
$11.90$595,075-0.80%
2024-08-23Saledirector
100,000
0.0084%
$11.75$1.18M+0.34%
2024-08-22Saledirector
100,000
0.0084%
$11.73$1.17M+0.77%
2024-08-21Saledirector
100,000
0.0084%
$11.75$1.18M+0.51%
2024-06-14Saledirector
264,300
0.0212%
$10.18$2.69M+15.63%
2024-06-13Saledirector
85,660
0.0071%
$10.52$900,741+13.14%
2024-05-28SaleChief Legal Officer
89,419
0.0075%
$10.38$928,429+12.76%
2024-03-13SaleSee Remarks
250,000
0.0211%
$12.09$3.02M-3.15%
2024-03-05SaleSee Remarks
24,353
0.0021%
$12.33$300,272-4.76%
2024-03-05Saledirector
20,000
0.0017%
$12.36$247,200-4.76%
2024-03-04SalePresident, Greater China
21,532
0.0018%
$12.51$269,314-5.26%
2024-02-23SaleSee Remarks
4,000
0.0003%
$13.50$54,000-13.38%
2024-02-15SaleSee Remarks
4,000
0.0003%
$12.50$50,000-8.39%
2024-01-04SaleSee Remarks
4,000
0.0003%
$11.50$46,000+1.51%
2023-12-14SaleSee Remarks
4,000
0.0003%
$10.50$42,000+12.99%
2023-11-24SalePresident, Greater China
14,937
0.0012%
$9.37$139,942+23.30%
2023-10-26Purchasedirector
19
<0.0001%
$9.01$171+28.59%

Insider Historical Profitability

<0.0001%
GOETTLER MICHAELChief Executive Officer
136796
0.0115%
$10.9510+8.94%
KORMAN HARRYdirector
94960
0.008%
$10.95100
KILTS JAMES Mdirector
64905
0.0054%
$10.9510<0.0001%
CORNWELL W DON
22031
0.0018%
$10.9540<0.0001%

VTRS Institutional Investors: Active Positions

Increased Positions405+35.5%89M+9.53%
Decreased Positions470-41.19%37M-3.92%
New Positions85New6MNew
Sold Out Positions88Sold Out4MSold Out
Total Postitions1,076-5.7%987M+5.61%

VTRS Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Vanguard Group Inc$1.59M11.81%141.03M+702,654+0.5%2024-09-30
Blackrock, Inc.$1.06M7.88%94.03M+1M+1.47%2024-09-30
State Street Corp$711,948.005.29%63.12M+1M+1.62%2024-09-30
Davis Selected Advisers$706,661.005.25%62.65M+5M+8.88%2024-09-30
Price T Rowe Associates Inc /Md/$550,297.004.09%48.79M-8M-14.14%2024-09-30
Pacer Advisors, Inc.$396,527.002.94%35.15M+35M+30,518.5%2024-12-31
Invesco Ltd.$344,537.002.56%30.54M-169,516-0.55%2024-09-30
Geode Capital Management, Llc$332,044.002.47%29.44M+439,584+1.52%2024-09-30
Deerfield Management Company, L.P. (Series C)$270,641.002.01%23.99M+3M+12.14%2024-09-30
Ameriprise Financial Inc$244,847.001.82%21.71M-154,381-0.71%2024-09-30
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.